cbdMD, Inc. (YCBD) stock
Close on Nov 12, 2026Market cap $4.40MP/E –Yield –
cbdMD, Inc. grew revenue 10.0% to $20.93M over the twelve months to Jun 30, 2026. Free cash flow was -$2.41M. At the latest close the market valued the company at $4.40M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $4.40M
- P/E ratio
- –
- Price to sales
- 0.21
- Price to book
- 0.54
- Dividend yield
- –
- Free cash flow yield
- -54.80%
Fundamentals
- Revenue
- $20.93M
- Net income
- -$2.89M
- EPS, diluted
- -$1.09
- Free cash flow
- -$2.41M
- Book value per share
- $0.77
- Diluted shares
- 11M
Trading
- Previous close
- $0.40
- Open
- $0.40
- Day's range
- $0.39 – $0.41
- Volume
- 55,108
- Average volume (20 days)
- 97,524
- Beta (5 years)
- 0.62
- 52-week range
- $0.33 – $2.56
- RSI (14 days)
- 48.6
- Volatility (1 year)
- 149.4%
- Relative volume
- 0.16×
- WACC
- 8.0%
Market cap history
Month-end market cap since 2017, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | YCBD | S&P 500 | Difference | YCBD per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +10.2% | -2.7% | +12.9 pts | ||
| 3 months | -34.4% | -1.7% | −32.6 pts | ||
| Year to date | -70.9% | +11.9% | −82.8 pts | ||
| 1 year | -49.3% | +12.0% | −61.3 pts | ||
| 3 years | -93.1% | +78.2% | −171.3 pts | -59.0% | +21.2% |
| 5 years | -99.9% | +73.2% | −173.2 pts | -77.3% | +11.6% |
Eleven years at a glance
Fiscal years 2015 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases cbdMD filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Update
- Results
- News
- News
About cbdMD
Perfumes, Cosmetics & Other Toilet Preparations
cbdMD, Inc. develops, manufactures, and markets natural wellness supplements and functional consumer products. The business offers broad-spectrum and full-spectrum hemp-derived cannabinoid items, including tinctures, gummies, capsules, and topicals under its core cbdMD label. It also provides pet supplements under Paw CBD, functional mushroom formulations through ATRX, and ready-to-drink cannabinoid beverages under the Herbal Oasis line. Its customer base includes individual consumers shopping online as well as business clients comprising regional retailers, specialty stores, and beverage wholesalers.
Company profile, executives and historycbdMD stock: common questions
What is cbdMD's stock price?
YCBD closed at $0.39 on Nov 12, 2026, down 0.66% on the day. Over the past 52 weeks it traded between $0.33 and $2.56.
What is cbdMD's market cap?
cbdMD was worth $4.40M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is YCBD's P/E ratio?
cbdMD lost money over fiscal 2025 (diluted EPS -$1.09), so it has no meaningful P/E ratio.
How much revenue does cbdMD make?
cbdMD reported revenue of $20.93M for the twelve months to Jun 30, 2026, up 10.0% from a year earlier.
Does cbdMD pay a dividend?
No. cbdMD has not paid a cash dividend over the last twelve months.
How has YCBD stock performed over the past year?
Including dividends, YCBD returned -49.3% over the past year, against +12.0% for the S&P 500.
How many YCBD shares are sold short?
0M shares were sold short at the latest FINRA report, 6.59% of the float, or 7.4 days of average trading volume.
Who are cbdMD's competitors?
Companies most similar to cbdMD by business, industry and size include AXIL, UG, CSCIF, CVSI, SLSN.
See a number that looks wrong?